173 related articles for article (PubMed ID: 33099376)
1. Forging the Future: 2018 Alopecia Areata Research Summit Summary Report.
Ellison A; Kranz D; Mesinkovska NA; Christiano AM; Shapiro J; Norris DA
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S1-S5. PubMed ID: 33099376
[TBL] [Abstract][Full Text] [Related]
2. Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights.
Kranz D; Ellison A; Mesinkovska NA; Christiano AM; Hordinsky MK; Harris JE
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S3-S8. PubMed ID: 29273102
[TBL] [Abstract][Full Text] [Related]
3. From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata.
Kranz D; Ellison A; Frelinger JA; Mackay-Wiggan J; Norris DA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):1-5. PubMed ID: 26551934
[TBL] [Abstract][Full Text] [Related]
4. Report from the International Dermatology Outcome Measures Initiative.
Perez-Chada LM; Merola JF; Armstrong AW; Garg A; Latella J; Gottlieb AB
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S80-S83. PubMed ID: 33099394
[TBL] [Abstract][Full Text] [Related]
5. Current State of Research and Summary of Preceding Summits.
Norris DA
J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S1-S2. PubMed ID: 29273097
[TBL] [Abstract][Full Text] [Related]
6. Overview of AA and Research Progress: What Have We Learned and Where Are We Headed?
Norris DA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):6-8. PubMed ID: 26551935
[TBL] [Abstract][Full Text] [Related]
7. Introduction to innovations in the immunology and clinical science of alopecia areata.
Kalabokes VD; Bergfeld WF; Christiano AM
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S1-4. PubMed ID: 24326539
[TBL] [Abstract][Full Text] [Related]
8. Treatment development program: the National Alopecia Areata Foundation's initiative for achieving safe and effective therapies.
Gelula RL
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S46-7. PubMed ID: 24326553
[TBL] [Abstract][Full Text] [Related]
9. International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting.
Zagona-Prizio C; Yousif J; Grant C; Mehta M; Rosmarin D; Silverberg N; Tan J; Larocca C; Shinohara M; Mostaghimi A; Kim B; Gulliver S; Gulliver W; Siegel D; Perez-Chada L; Merola J; Gottlieb A; Armstrong A
J Drugs Dermatol; 2022 Aug; 21(8):867-874. PubMed ID: 35946973
[TBL] [Abstract][Full Text] [Related]
10. Two paradoxical reactions in a patient with psoriasis and psoriatic arthritis: Adalimumab-induced hidradenitis suppurativa and secukinumab-induced alopecia areata.
Öğüt ND
J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e468-e469. PubMed ID: 36151938
[No Abstract] [Full Text] [Related]
11. The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms.
Wyrwich KW; Kitchen H; Knight S; Aldhouse NVJ; Macey J; Nunes F; Dutronc Y; Mesinkovska NA; Ko JM; King BA
J Investig Dermatol Symp Proc; 2020 Nov; 20(1):S71-S77. PubMed ID: 33099392
[TBL] [Abstract][Full Text] [Related]
12. Development of Uniform Protocol for Alopecia Areata Clinical Trials.
Solomon JA
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):63-6. PubMed ID: 26551952
[TBL] [Abstract][Full Text] [Related]
13. The new biologics in psoriasis: possible treatments for alopecia areata.
McMichael AJ
J Investig Dermatol Symp Proc; 2003 Oct; 8(2):217-8. PubMed ID: 14582677
[TBL] [Abstract][Full Text] [Related]
14. Establishing and prioritizing research questions for the treatment of alopecia areata: the Alopecia Areata Priority Setting Partnership.
Macbeth AE; Tomlinson J; Messenger AG; Moore-Millar K; Michaelides C; Shipman AR; Kassim JM; Brockley JR; Szczecinska W; Farrant P; Robinson R; Rodgers J; Chambers J; Upadhyaya S; Harries MJ
Br J Dermatol; 2017 May; 176(5):1316-1320. PubMed ID: 27696375
[TBL] [Abstract][Full Text] [Related]
15. IL-17 inhibition: is it the long-awaited savior for alopecia areata?
Ramot Y; Marzani B; Pinto D; Sorbellini E; Rinaldi F
Arch Dermatol Res; 2018 Jul; 310(5):383-390. PubMed ID: 29497840
[TBL] [Abstract][Full Text] [Related]
16. Universal protocol for alopecia areata clinical studies.
Mesinkovska NA; Bergfeld WF
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S48. PubMed ID: 24326554
[TBL] [Abstract][Full Text] [Related]
17. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
[TBL] [Abstract][Full Text] [Related]
18. Contact immunotherapy-induced Renbök phenomenon in a patient with alopecia areata and psoriasis vulgaris.
Ito T; Hashizume H; Takigawa M
Eur J Dermatol; 2010; 20(1):126-7. PubMed ID: 19822483
[No Abstract] [Full Text] [Related]
19. Alopecia areata: autoimmune basis of hair loss.
Alexis AF; Dudda-Subramanya R; Sinha AA
Eur J Dermatol; 2004; 14(6):364-70. PubMed ID: 15564197
[TBL] [Abstract][Full Text] [Related]
20. An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping Review.
Xia E; Li SJ; Drake L; Reyes-Hadsall S; Mita C; Drucker AM; Mostaghimi A
J Invest Dermatol; 2023 Jul; 143(7):1133-1137.e12. PubMed ID: 37115113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
